BiomimX® Srl

🚀 Are you ready for the EUROoCS Conference 2024? We are! This year, the #EUROoCS annual meeting is hosted and organised by Politecnico di Milano and our Co-founders and Professors at #PoliMI Paola Occhetta and Marco Rasponi will be Co-chairs of the Conference!!   Don’t miss the opportunity meet us at Booth S9 and to discover the outstanding work by our team members exhibiting their posters: 🗓 July 4th, 2024 🕒 12:30-14:00 PM -     Caterina Pernici: T-106: “Development of a tool to elucidate the clinical phenotype of patients affected by genetic cardiomyopathy in a 3D beating heart-on-chip platform” -     Elena Vatrano: T-110: “On-chip tracking of human mesenchymal cells gene expression profile to unravel mechanically driven chondrogenesis processes” 🗓 July 5th, 2024 🕒 12:30-14:00 PM -     Marco Mondini: F-116: “Development and characterization of mechanical-stimulated atrial and ventricular 3D heart-on-chip models” -     Erika Ferrari: F-064: “Assessing the feasibility of innovative Liver-on-Chip models for in vitro hepatotoxicity screening”   #OrganonChip #EUROoCS2024 #Milano

It was wonderful to share our work with this amazing community at The Extracellular Matrix Pharmacology Congress and to get the latest news in the field of ECM-related pathology and pharmacology. Thanks to the organizers of the Congress and to all the attendees. #ECM2024 #CardiacFibrosis #Osteoarthritis #HepaticArchitecture

📌 Today, our CEO, Dr. Paola Occhetta, will take the stage for an oral presentation at The Extracellular Matrix Pharmacology Congress in Copenhagen! #ECM2024 #CardiacFibrosis #OrganonChip

📢 Exciting announcement: we have a new entry in the BiomimX® Srl Team!   Elena Vatrano will be our new Junior R&D Scientist. After successfully completing her Master Degree in Biomedical Engineering at Politecnico di Milano, Elena joined our team!   ✨ Welcome on board Elena! ✨   #GrowingTeam #RnDScientist

Don't forget to attend the presentation by our CEO, Dr. Paola Occhetta, today at MPS World Summit in Seattle! Details: 🔬 MPS for cardiovascular diseases 🗓 11th June, 2024 🕒 12:00 - 12:20 PM 📍 Seattle Convention Center - Summit Building, 320-32 #MPS2024 #OrganonChip #Cardiomyopathies

📢 Thrilling announcement: BiomimX® Srl will be one of the exhibitors at the The Extracellular Matrix Pharmacology Congress in Copenhagen, Denmark, next week! Meet our team Booth # 13 and join our CEO, Dr. Paola Occhetta for her presentation on the pathological hallmarks of cardiac fibrosis in a OoC for predicting drug efficacy. Also, don't miss our posters # 107 and # 125 by Erika Ferrari and Stefano Piazza! #ECM2024 #CardiacFibrosis #LiveronChip #Osteoarthritis #Copenhagen

🎉 Congratulations to our Junior R&D Product Engineer Caterina Pernici for winning the Best Poster Award at European Society of Toxicology in Vitro ESTIV Congress!! 🎉 Also, Erika Ferrari won the Travel Grant and Caterina Pernici received the EUROTOX Toxicology Societies Travel Grant! A big thank you to the organization of the Congress and to all the attendees for this memorable event! #ESTIV2024 #Toxicology #Cardiotoxicity #BestPoster #OrganonChip

🌍 This morning, our Commercial Science Leader, Dr. Erika Ferrari presented her work on novel physiologic-like liver-on-chip models for in vitro hepatotoxicity screening at the European Society of Toxicology in Vitro ESTIV International Congress in Prague. Thanks to all the attendees and don’t forget to visit our Stand #23! #ESTIV2024 #Toxicology #Prague #OrganonChip

📢 Updates: Caterina Pernici will present her poster during Session III on Wednesday 5th June, 18:30-19:30.

📢 Exciting announcement: our co-founders, Dr. Paola Occhetta & Dr. Marco Rasponi, will be in Seattle for the MPS World Summit! Don’t miss the presentation by our CEO, Dr. Paola Occhetta to learn how our beating heart-on-chip can elucidate the clinical phenotype of patients affected by genetic cardiomyopathies. MPS for cardiovascular diseases: 🗓 11th June, 2024 🕒 12:00 - 12:20 PM 📍 Seattle Convention Center - Summit Building, 320-32   See you in Seattle!   #MPSSeattle2024 #OrganonChip #InVitro #Cardiomyopathies